Virtu KCG Holdings’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Virtu KCG Holdings’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$98K	Buy	+206	New	+$156K	﹤0.01%	2422
2015 Q3	–	Sell	-77	Closed	-$154K	–	3955
2015 Q2	$154K	Buy	+77	New	+$197K	﹤0.01%	2739

Other funds holding HTGM

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIM

Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

Virtu KCG Holdings's HTGM Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q2 2017: 206 shares worth $98K. The stake represents ﹤0.01% of the portfolio and ranks #2422 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in HTGM as recently as Q2 2015.

Virtu KCG Holdings first reported a position in HTGM in Q2 2015 and has held it in 2 quarters since. The position peaked at $154K in Q2 2015. 18 funds tracked by Wall St. Rank hold HTGM as of Q2 2017.

Virtu KCG Holdings held 206 shares of HTG Molecular Diagnostics, Inc. Common Stock worth $98K as of Q2 2017.
HTG Molecular Diagnostics, Inc. Common Stock was a new Virtu KCG Holdings position in Q2 2017.
HTG Molecular Diagnostics, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2422 holding.
Virtu KCG Holdings first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2015 and has held it in 2 quarters since.
Virtu KCG Holdings's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $154K in Q2 2015.
18 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.